Sermorelin stimulates your body's own growth hormone production — supporting metabolic health, body composition, sleep quality, and physical recovery. Clinician-guided protocols. Licensed providers. Available nationwide.
Unlike direct growth hormone administration, sermorelin stimulates the pituitary gland to produce growth hormone naturally — maintaining the physiological feedback mechanisms that regulate GH levels. This is a fundamental distinction in how the therapy works and why it's used in clinical wellness protocols.
Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to produce and secrete growth hormone naturally.
Growth hormone (GH) is produced by the pituitary gland under the direction of growth hormone-releasing hormone (GHRH) from the hypothalamus. As we age, the pituitary's responsiveness to GHRH declines, leading to decreased GH production — a process sometimes referred to as somatopause.
Sermorelin works by binding to GHRH receptors in the pituitary, stimulating the synthesis and pulsatile release of endogenous growth hormone. This results in downstream increases in IGF-1 (insulin-like growth factor 1), the primary mediator of growth hormone's effects on body composition, metabolism, and tissue repair.
Because sermorelin works through the body's own regulatory systems — rather than introducing growth hormone directly — the physiological feedback mechanisms that prevent excess GH levels remain intact. This is a clinically meaningful distinction when evaluating the risk profile of growth hormone support therapies.
Sermorelin therapy at SEVEN may be considered as part of an integrated metabolic health protocol alongside NAD+ therapy or other programs when clinically appropriate.
The following represents areas of clinical consideration for sermorelin therapy. Individual responses vary and outcomes are not guaranteed. All protocols are clinician-supervised.
Growth hormone plays a role in fat metabolism and muscle protein synthesis. Supporting GH levels through sermorelin may contribute to improved lean body composition over time, particularly when combined with appropriate nutrition and activity.
Growth hormone is predominantly released during deep sleep. Many patients on sermorelin report improvements in sleep quality and depth, which is consistent with the physiological relationship between GH and sleep architecture.
Improved GH levels are associated with enhanced physical recovery, reduced fatigue, and improved energy. These effects are mediated through metabolic and tissue repair pathways influenced by IGF-1.
Growth hormone influences glucose metabolism, lipid oxidation, and body composition in ways that support overall metabolic health. Sermorelin's effect on GH levels may contribute to improved metabolic function.
Growth hormone and IGF-1 have neurotrophic effects. Some patients report improvements in mental clarity and cognitive performance on sermorelin protocols, though evidence in this area continues to develop.
IGF-1 — the downstream mediator of GH — plays a role in tissue repair and regeneration. Sermorelin protocols may support recovery from physical stress and age-related tissue maintenance challenges.
Individual results vary and are not guaranteed. Sermorelin's adult wellness applications represent off-label use. All protocols are reviewed and prescribed by licensed clinicians following individual health intake evaluation.
Complete the early access form at getmyseven.com. Initial onboarding will be limited — join now to secure your spot.
Complete a detailed online health intake covering your health history, symptoms, current medications, and wellness goals. No in-person visit required.
A licensed clinician reviews your intake and determines whether sermorelin therapy is clinically appropriate for your situation. Protocol design is individualized.
If approved, your prescription is coordinated through SEVEN's clinical infrastructure. Medication is prepared and shipped directly to your door with clear administration instructions.
Provider access and clinical support throughout your program. Sermorelin protocols are typically evaluated over 3-6 months to assess clinical response and adjust as appropriate.
Eligibility is determined by a licensed clinician following individual health intake review. The following reflects general clinical considerations.
Growth hormone decline typically accelerates after age 30. Adults experiencing symptoms associated with declining GH levels may be candidates for sermorelin protocols.
Adults focused on body composition, metabolic health, and longevity who are looking to support GH levels as part of a comprehensive wellness protocol.
Adults seeking to support physical recovery, endurance, and lean body composition through improved growth hormone activity.
Sermorelin is contraindicated in patients with active malignancy due to IGF-1's role in cell proliferation. This and other contraindications are reviewed during the clinical intake process.
Treatment eligibility is determined exclusively by a licensed clinician following review of your individual health intake. This is not a guarantee of treatment approval.